These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 15650515

  • 1. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
    Susanna R, Medeiros FA, Vessani RM, Giampani J, Borges AS, Jordão ML.
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
    [Abstract] [Full Text] [Related]

  • 2. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
    Susanna R, Giampani J, Borges AS, Vessani RM, Jordao ML.
    Ophthalmology; 2001 Feb; 108(2):259-63. PubMed ID: 11158796
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE, Paris G, Trigo Y, Pena M.
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [Abstract] [Full Text] [Related]

  • 4. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
    Saito M, Takano R, Shirato S.
    Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
    [Abstract] [Full Text] [Related]

  • 5. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.
    Jampel HD, Bacharach J, Sheu WP, Wohl LG, Solish AM, Christie W, Latanoprost/Unoprostone Study Group.
    Am J Ophthalmol; 2002 Dec; 134(6):863-71. PubMed ID: 12470755
    [Abstract] [Full Text] [Related]

  • 6. A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension.
    Tsukamoto H, Mishima HK, Kitazawa Y, Araie M, Abe H, Negi A, Glaucoma Study Group.
    J Glaucoma; 2002 Dec; 11(6):497-501. PubMed ID: 12483094
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [Abstract] [Full Text] [Related]

  • 8. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
    Aung T, Chew PT, Oen FT, Chan YH, Thean LH, Yip L, Lim BA, Soh J, Seah SK.
    Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
    Tamada Y, Taniguchi T, Murase H, Yamamoto T, Kitazawa Y.
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl.
    Kobayashi H, Kobayashi K, Okinami S.
    J Glaucoma; 2001 Dec; 10(6):487-92. PubMed ID: 11740220
    [Abstract] [Full Text] [Related]

  • 13. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Stewart WC, Sharpe ED, Stewart JA, Holmes KT, Latham KE.
    Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
    [Abstract] [Full Text] [Related]

  • 14. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial.
    Mansouri K, Orguel S, Mermoud A, Haefliger I, Flammer J, Ravinet E, Shaarawy T.
    Br J Ophthalmol; 2008 Mar; 92(3):332-6. PubMed ID: 18211927
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [Abstract] [Full Text] [Related]

  • 16. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
    Toris CB, Zhan G, Camras CB.
    Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC, Reis AS, Vidal KS, de Moraes CG, Suzuki R, Hatanaka M, Susanna R.
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J, Li X, Sun X, He X, Zhang H.
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.